STRO - Sutro Biopharma, Inc. -  [ ]

Seasonality of Returns By Period

Average daily return by calendar bucket (ClosePriceSA).

Day of Week

Week of Month

Month of Year

Seasonal Path

YTD vs Last Year vs Lookback Avg · closes rebased to 100 at each year's first session
Ticker Details
Sutro Biopharma, Inc.
IPO Date: October 12, 2018
Sector: Healthcare
Industry: Biotech
Market Cap: $243.08M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.36 | 3.84%
Avg Daily Range (30 D): $0.43 | 2.57%
Avg Daily Range (90 D): $0.83 | 3.43%
Institutional Daily Volume
Avg Daily Volume: .43M
Avg Daily Volume (30 D): .24M
Avg Daily Volume (90 D): .26M
Trade Size
Avg Trade Size (Sh.): 118
Avg Trade Size (Sh.) (30 D): 61
Avg Trade Size (Sh.) (90 D): 55
Institutional Trades
Total Institutional Trades: 772
Avg Institutional Trade: $1.6M
Avg Institutional Trade (30 D): $1.34M
Avg Institutional Trade (90 D): $1.67M
Avg Institutional Trade Volume: .03M
Avg Institutional Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $1.69M
Avg Closing Trade (30 D): $1.1M
Avg Closing Trade (90 D): $2.25M
Avg Closing Volume: 24.01K
 
News
Apr 19, 2026 @ 11:45 PM
Sutro Biopharma Presents Promising Preclinical Dat...
Source: Na
Feb 10, 2026 @ 12:00 PM
Sutro Biopharma Announces Pricing of $110.0 millio...
Source: Na
Dec 3, 2025 @ 1:00 PM
Sutro Biopharma Announces First Cohort of Patients...
Source: Sutro Biopharma
Nov 12, 2025 @ 3:00 PM
Sutro Biopharma Highlights Next-Generation ADC Inn...
Source: Sutro Biopharma
Nov 3, 2025 @ 1:00 PM
Sutro Biopharma Announces Participation at the 16t...
Source: Sutro Biopharma
Financials
  TTM Q2 2026 Q1 2026
Basic EPS $-26.64 $-2.33 $-2.94
Diluted EPS $-26.64 $-2.33 $-2.94
Revenue $45.7M $9.84M $14.52M
Gross Profit
Net Income / Loss $-180.64M $-38.53M $-38.48M
Operating Income / Loss $-146.05M $-29.89M $-29.66M
Cost of Revenue
Net Cash Flow $-9.69M $-19.35M $15.55M
PE Ratio    
Splits
Dec 03, 2025 1:10